Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy.
about
Combined Bone Marrow and Kidney Transplantation for the Induction of Specific ToleranceTolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal BlockageNew insights into the mechanisms of Treg functionTempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cellsRegulatory T cell-derived exosomes: possible therapeutic and diagnostic tools in transplantationAdipose-derived stromal cells promote allograft tolerance induction.Islet cell transplant and the incorporation of Tregs.Therapeutic regulatory T cells subvert effector T cell function in inflamed islets to halt autoimmune diabetes.Rejection triggers liver transplant tolerance: Involvement of mesenchyme-mediated immune control mechanisms in mice.Targeting Treg signaling for the treatment of autoimmune diseasesInduced Foxp3(+) T Cells Colonizing Tolerated Allografts Exhibit the Hypomethylation Pattern Typical of Mature Regulatory T CellsUtilization of leukapheresis and CD4 positive selection in Treg isolation and the ex-vivo expansion for a clinical application in transplantation and autoimmune disorders.Regulatory T cells as immunotherapy.Lung transplantation: chronic allograft dysfunction and establishing immune tolerance.Tolerance in organ transplantation: from conventional immunosuppression to extracellular vesicles.Interpretation of transplant biopsies and immune responses following Treg cell therapyRestoring Regulatory T Cells in Type 1 Diabetes.Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells.Transplant trials with Tregs: perils and promises.Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor.Donor-Reactive Regulatory T Cell Frequency Increases During Acute Cellular Rejection of Lung Allografts.Regulatory T Cells: Molecular and Cellular Basis for Immunoregulation.Dysfunctional immunoregulation in human liver allograft rejection associated with compromised galectin-1/CD7 pathway function.Stability of Chimerism in Non-Obese Diabetic Mice Achieved By Rapid T Cell Depletion Is Associated With High Levels of Donor Cells Very Early After Transplant.Transplant tolerance by Treg therapy.Direct recognition of hepatocyte-expressed MHC class I alloantigens is required for tolerance inductionT cell Allorecognition Pathways in Solid Organ Transplantation
P2860
Q26745435-58ED5ECB-C14F-499E-BCD0-CFAF3BF2FF17Q26778646-2D2F8FE8-187A-4E42-88E0-38480B86EB46Q26823540-74F1F46F-E633-4459-9484-50045B882F28Q26851647-C03E0A95-31CA-4865-B922-726D05D30A4FQ34454926-F5E6BF6C-0383-4CA6-85A1-43C2E6441EB9Q34601943-ACD72E7F-97D9-456B-8495-C90AA32114D4Q34729072-770E2BC1-5C7B-4603-A80B-7BFFF7CC7F6BQ35205330-B15A9F75-AEF2-429C-9FF0-2B3C73C5A2C5Q35995670-713DB6B8-6597-4199-869D-AD58DD9DCD0DQ36372616-920DD83D-827C-41B7-B040-57A525377E0EQ36786632-EB62E980-2929-408F-AB1F-41C4A323C1FAQ37694801-F022322E-2695-447B-8EA5-E458D2252665Q38191610-1CC457F5-26D4-497D-84DF-B59B90AC04DAQ38224758-437F37BD-A49C-420E-8900-7B550ABA61FDQ38256369-8511E5ED-D2B9-4AF3-8614-512BB7C22BF6Q38260080-37B8171C-990B-4F5B-84FA-157BFD5AE3E2Q38963375-BE4F7E35-E82D-4A92-AE3B-D488F57A7E45Q39062014-424C4AAC-F12F-449F-A239-935BF78087DFQ39279238-1CA9DF01-1A24-4E9C-80B3-D4DA0B260BE3Q39406891-E262D139-81A3-4491-8C48-731D257C1167Q40402774-685784A6-0276-4251-9B37-C24545443A00Q41658209-C9B8C445-AC73-48B9-BC45-FB838CDEF5C2Q48668293-06ED00F0-E20E-4B28-A78E-059BD2A049FAQ49789996-5B5694F0-76C6-4FEA-A27B-917AEA7AF499Q53824120-4D11AFFB-A353-4116-9ECB-6FBF7FA61678Q54686684-BE216987-3ACA-4244-B2D9-7DD9C3579262Q58792298-70DF0593-0287-40DB-82F9-FC16C6CDD39BQ59130097-1124602D-47E8-4947-AC21-17D741D98E30
P2860
Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Attenuation of donor-reactive ...... ing regulatory T cell therapy.
@en
Attenuation of donor-reactive ...... ing regulatory T cell therapy.
@nl
type
label
Attenuation of donor-reactive ...... ing regulatory T cell therapy.
@en
Attenuation of donor-reactive ...... ing regulatory T cell therapy.
@nl
prefLabel
Attenuation of donor-reactive ...... ing regulatory T cell therapy.
@en
Attenuation of donor-reactive ...... ing regulatory T cell therapy.
@nl
P2093
P2860
P356
P1476
Attenuation of donor-reactive ...... ing regulatory T cell therapy.
@en
P2093
P2860
P356
10.1111/AJT.12509
P407
P577
2013-11-13T00:00:00Z